Research Progress of SGLT2 Inhibitors in Cancer Treatment by Miao X, Zhang J, Huang W, Wang Y, Jin A, Cao J, Zhao Z

Subjects: Get full text

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation by Christodoulos Dolapsakis, Emmanouil Karofylakis, Stamatios Chalvatzis

Subjects: “…sglt2 inhibitors…”
Get full text

The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report by Diana Alegre-González, Sandra García-Guerreros, Sara Martínez-Hernández, Ana Yasmina Brito-Díaz, Marta Casañas-Martínez, Ramón Baeza-Trinidad

Subjects: “…sglt-2 inhibitors…”
Get full text

The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus by Rujie Zheng, Wenjuan Song, Jie Lu, Mingyue Yuan, Xiaotong Sun, Chengzhi Lu

Subjects: “…SGLT2 inhibitors…”
Get full text

Exacerbation of diabetes due to F. Nucleatum LPS-induced SGLT2 overexpression in the renal proximal tubular epithelial cells by Aiko Seki, Koichiro Kajiwara, Jumpei Teramachi, Masahiko Egusa, Takuya Miyawaki, Yoshihiko Sawa

Subjects: Get full text

The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) by Denda Nikola I., Maletin Nemanja Z., Atanasković Marko B., Vučković Biljana A., Rašković Aleksandar L.

Subjects: Get full text

The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature by Silvia Ciraolo, Agnieszka Kulczycka-Rowicka, Joanna Wojda, Katarzyna Lesiczka-Fedoryj, Anna Walczak, Zuzanna Kościuszko, Adam Sobiński, Matylda Czerwonka, Katarzyna Kurza, Julianna Podolec

Subjects: “…SGLT2 inhibitors…”
Get full text

The impact of sodium-glucose cotransporter-2 inhibitors on the incidence, therapy, and outcomes of fournier gangrene: insights from a systematic review of case reports by Yufi Aulia Azmi, Firas F. Alkaff, Kevin Muliawan Soetanto, Soetojo Wirjopranoto, Maarten J. Postma, Abdul Khairul Rizki Purba

Subjects: Get full text

Advances in sodium-glucose transporter protein 2 inhibitors and tumors by Jiaqi Wang, Wenyong Yang

Subjects: “…SGLT2i…”
Get full text

Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study) by Md Faruque Pathan, Nazma Akter, Marufa Mustari, M. Saifuddin, Mirza Sharifuzzaman, Mohammad Motiur Rahman, Mohammed Ripon, S. M. Mohiuddin, A. B. M. Kamrul-Hasan, Mohammad Abdul Hannan, Muhammad Shah Alam, Samira Mahjabeen, Faria Afsana, Muhammed Abu Bakar, Tahniyah Haq, Afsar Ahammed, Samir Kumar Talukder, Sourav Sarkar, Shahjada Selim

Subjects: Get full text

Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema by Takuya Oyakawa, Keita Miura, Nao Muraoka, Kei Iida, Ayano Fujita, Tateaki Naito, Toshiaki Takahashi

Subjects: Get full text

Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation by Selim Aydemir, Sidar Şiyar Aydın, Emrah Aksakal, Onur Altınkaya, Murat Özmen, Oğuzhan Birdal

Subjects: Get full text

A study on the pharmacovigilance of various SGLT-2 inhibitors by Yanwen Dong, Yangyang Wang, Yangyang Wang, Xiaomei Lan, Xiaomei Lan, Huiyan Zeng, Huiyan Zeng

Subjects: “…SGLT2i…”
Get full text

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration by Zhijie Liu, Yiming Fan, Jun Guo, Ning Bian, Dongdong Chen

Subjects: Get full text

Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives by Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou

Subjects: Get full text

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential by Alexander Fuerlinger, Alina Stockner, Simon Sedej, Mahmoud Abdellatif

Subjects: Get full text

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes by Bethany Murphy, Simran Chahal, Elleigh Shepherd, Nicole Taylor, Austin Camp

Subjects: Get full text

Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production by Yan Tian, Chenxia Zhou, Qun Yan, Ziyi Li, Da Chen, Bo Feng, Jun Song

Subjects: “…SGLT2i…”
Get full text

Real-world effectiveness and safety of sodium-glucose co-transporter 2 inhibitors in chronic kidney disease by Supattra Hunsuwan, Sarinya Boongird, Atiporn Ingsathit, Wanchana Ponthongmak, Nattawut Unwanatham, Gareth J McKay, John Attia, Ammarin Thakkinstian

Subjects: Get full text

Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications by Basavana Goudra, Geno J. Merli, Michael Green

Subjects: Get full text